Damona Pharmaceuticals given FDA approval for trial of DPX-101 for brain disorders

Retrieved on: 2024-11-05 17:40:25

Tags for this article:

Click the tags to see associated articles and topics

Damona Pharmaceuticals given FDA approval for trial of DPX-101 for brain disorders. View article details on hiswai:

Excerpt

The gold standard of business intelligence. ... The drug is designed to treat cognitive disabilities in major depressive disorder and other brain ...

Article found on: www.clinicaltrialsarena.com